Efficacy and safety of ARNI in high-risk patients in the PIONEER-HF trial - PACE-CME

Efficacy and safety of ARNI in highrisk patients in the PIONEERHF trial

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
CME/CE
Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
0.25 credits
- Riccardo Maria Inciardi, MD, PhD
0.25 credits
Greater reductions in NT-proBNP with dapagliflozin/spironolactone combination therapy in HFmrEF/HFpEF
Greater reductions in NT-proBNP with dapagliflozin/spironolactone combination therapy in HFmrEF/HFpEF
ESC Heart Failure 2025
Greater reductions in NT-proBNP with dapagliflozin/spironolactone combination therapy in HFmrEF/HFpEF
- João Pedro Ferreira, MD, PhD
Effects of a switch in fluid management in patients with chronic HF
Effects of a switch in fluid management in patients with chronic HF
ESC Heart Failure 2025
Effects of a switch in fluid management in patients with chronic HF
- Job Herrmann, MD
Simplified one-step titration of vericiguat in patients with HF
Simplified one-step titration of vericiguat in patients with HF
ESC Heart Failure 2025
Simplified one-step titration of vericiguat in patients with HF
- Stephen J. Greene, MD